Skip to content

Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial

Impact of the Combination of Pressure Support and Positive End Expiratory Pressure During Spontaneous Breathing Trial Versus T-piece on the Time to Successful Extubation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03861117
Acronym
SBT-ICU
Enrollment
98
Registered
2019-03-04
Start date
2019-05-10
Completion date
2023-06-01
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critically Ill Adult Patients With Difficult Weaning

Keywords

Critical care, spontaneous breathing trial, T-piece, positive end-expiratory pressure, difficult weaning

Brief summary

The aim of this study is to assess if a bundle associating pressure support and positive end-expiratory pressure during spontaneous breathing trial and detection by T-piece of patients with high-risk of extubation failure can reduce the time to successful extubation in critically ill patients.

Interventions

PROCEDUREAssisted strategy

Daily spontaneous breathing trial (SBT) with 7 cmH2O pressure support and 5 cmH2O positive end-expiratory pressure are performed to assess weanability. In case of success, a SBT with T-piece is performed to determine if the patients is at high risk of extubation failure. In this case and/or in the presence of risk factors, systematic non-invasive ventilation is applied after extubation.

PROCEDURENon assisted strategy

Daily spontaneous breathing trials (SBT) with T-piece are performed to assess weanability. In the presence of risk factors, systematic non-invasive ventilation is applied after extubation.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient 18 years old or more * Intubated and ventilated in intensive care unit for more than 24 hours * Patient ready for weaning evaluation * Failure of a first T-piece SBT

Exclusion criteria

* Chronic neuromuscular disease * Guillain-Barré Syndrome * Central nervous system disease with consciousness disorder * Tracheostomy * Chronic disease with life expectancy less than 1 year * Pregnancy, breast feeding * Withholding life support regarding a reintubation * Prisoner or patient interned in psychiatric hospital * Guardianship * Language barrier * Lack of medical insurance * Lack of the patient's consent (or of the next of kin where appropriate) * Patient under an exclusion period after enrollment in another research study

Design outcomes

Primary

MeasureTime frameDescription
Time (hours) to successful extubation90 daysSuccessful extubation is defined as extubation without retintubation within the 7 following days.

Secondary

MeasureTime frameDescription
Invasive mechanical ventilation duration90 daystime (hours) spent on invasive mechanical ventilation since inclusion
duration of non-invasive and invasive mechanical ventilation90 daystime (hours) spent on invasive or non mechanical ventilation since inclusion
ventilator-free days at Day 9090 days90 minus the number of days spent on invasive mechanical ventilation (days) since inclusion. Zero day is allocated to dead patients.
Rate of first extubation90 dayspercentage (%) of patients with a first successful extubation divided by the total number of patients per group
hospital length of stay90 daystime (days) spent in the hospital from inclusion until discharge or death
Day 90 mortality90 dayspercentage (%) of patients dead at Day 90
reintubation rate90 dayspercentage (%) of the number of patients with any reintubation divided by the number of patients per group
Intensive care unit length of stay90 daystime (days) spent in intensive care unit from inclusion until discharge or death

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026